Project Overview The TAM (Translational Algorithmic Mapping) project represents a pioneering conceptual architecture designed to bridge the epistemological gap between qualitative Ayurvedic phenotyping and quantitative differential gene expression (DGE) profiling. The core innovation lies in the resolution of Diagnostic Latency—the subclinical interval wherein molecular dysregulation proceeds without observable phenotypic manifestation. By encoding Ayurvedic variables (Agni, Dosha, Dhatu Sarata) into continuous numerical feature vectors, the TAM Engine predicts probabilistic transcriptomic shifts in key barrier and inflammatory genes (e.g., FLG, LOR, COL1A1, NRF2). This framework facilitates a transition from reactive dermatology to a predictive, precision-based preventative model. Statement of Intellectual Provenance This project, including its logical structure, the mapping of the Gut-Skin axis through the SCFA-HDAC-FLG regulatory cascade, and the four-layer computational workflow (Encoding, Weighting, ML-Readiness, and Reporting), is the sole conceptual creation of Valentina Luongo. The architecture is derived from a proprietary synthesis of ancient metabolic observations and modern transcriptomic research. The methodology’s predictive nature is based on the theoretical translation of Ayurvedic "Agni" into epigenetic silencing/activation coefficients and "Dosha" into cytokine/microRNA signaling environments. Conceptual Pillars of the Methodology This architecture, conceived entirely by Valentina Luongo, rests on four proprietary conceptual pillars: The SCFA-HDACi-FLG Pipeline: a theoretical model where Agni (metabolic efficiency) serves as a proxy for the production of short-chain fatty acids, acting as histone deacetylase inhibitors to modulate the expression of the Filaggrin gene. The Dosha-Cytokine Signaling Environment: the translation of constitutional types into specific microRNA and cytokine profiles (e.g., Pitta-dominance as a proxy for IL-6 and CXCL1 upregulation). Predictive Latency Quantification (Delta): an algorithmic estimation of the temporal gap between molecular "priming" and phenotypic "eruption." Nutritional Cluster Targeting (ANC): a system of mapping dietary inputs (Ayurvedic Nutritional Clusters) to specific genetic pathways (e.g., ANC2 for Keap1-NRF2 activation). Professional Liability and Research Disclaimer I. Theoretical Nature of the Work: the TAM Framework is presented as a theoretical computational model. All algorithms, transfer functions, and predictive outputs generated by the TAM Engine are hypothetical constructs intended for academic research and methodological exploration. II. Limitation of Author Responsibility: Valentina Luongo’s role is strictly confined to the conceptual design and architectural ideation of the framework. The Author does not engage in clinical practice, does not diagnose medical conditions, and does not prescribe therapeutic interventions. III. Requirement for Empirical Validation: the TAM Engine is "ML-Ready" but requires empirical calibration. All predictive data must be validated through peer-reviewed laboratory testing and controlled longitudinal studies. The Author is not responsible for any diagnostic errors or clinical misinterpretations arising from the use of this uncalibrated theoretical model. IV. Clinical and Medical Disclaimer: this prospectus does not constitute medical advice. Any application of the TAM methodology in a clinical or diagnostic setting must be overseen by qualified medical practitioners, licensed bioinformaticians, and in compliance with local health regulations and ethical standards (e.g., GDPR, HIPAA). V. Indemnification: Users, researchers, or institutional partners agree to hold Valentina Luongo harmless from any legal claims, liabilities, or damages resulting from the use, misuse, or dissemination of the TAM methodology or its predicted outcomes. Proprietary Technology & Disclosure Policy Undisclosed Python Engine: the operational source code (TAM Engine), including the specific interaction weighting matrices, the proprietary beta-coefficients for gene-target mapping, and the automated reporting logic, remains strictly undisclosed and proprietary.
V. Luongo (Tue,) studied this question.